Loading...
Bisacodyl — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Bisacodyl
2025-Q4
Comprehensive analysis of India’s bisacodyl export trade — suppliers, buyers, prices, routes, and every shipment record.
125
Shipments
$647K
Trade Value
54
Suppliers
43
Buyers
41
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/bisacodyl
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s bisacodyl trade — 2025-Q4
KEY TAKEAWAY
Bisacodyl 2025-Q4 exports total $647.5K across 41 countries, with DRREDDYS LABORATORIES LTD commanding 20.3% market share.
TOTAL SHIPMENTS
125
2025-Q4
EXPORT VALUE
$647.5K
FOB USD
TOTAL QUANTITY
40.7M
units shipped
INDIAN SUPPLIERS
54
unique exporters
GLOBAL BUYERS
43
unique importers
DESTINATIONS
41
countries
MEDIAN UNIT PRICE
$0.155
per unit
TOP-5 SHARE
57.8%
of total USD
BRANDED SHARE
55.2%
69 shipments
DOSAGE FORMS
2
product types
6 KEY FINDINGS
1
DRREDDYS LABORATORIES LTD is India's #1 Bisacodyl exporter with $131.6K (20.3% market share).→ §5, Indian Supplier Rankings
2
Bisacodyl reached 41 countries, with United Kingdom as the top destination ($196.0K).→ §4, Global Destination Map
3
Market concentration is low (HHI: 932) — top 10 suppliers control 78.3% of exports.→ §5, Indian Supplier Rankings
4
93.0% of buyers (40 of 43) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (93.2%) across 2 dosage forms.→ §7, Price Benchmarks
6
40 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 DRREDDYS LABORATORIES LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian bisacodyl exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Bisacodyl report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial bisacodyl trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian bisacodyl suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Bisacodyl India trade report
Product scope
Bisacodyl
All variants merged — branded and generic formulations of bisacodyl
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
125
Every commercial bisacodyl trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a steady rise: Oct $118.4K, Nov $181.2K, Dec $347.9K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$118.4K
Oct USD
17 shipments
2
$181.2K
Nov USD
+53.0% MoM
3
$347.9K
Dec USD
+92.0% MoM
4
Steady rise
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 53.0% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $118K, making it the weakest month by value.
Fig 3.2 Q4 cumulative USD reached $647K.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $63K rise in Nov, $167K recovery in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $118K | 17 shipments |
| Nov | $181K | 36 shipments |
| Dec | $348K | 72 shipments |
| Q4 Total | $647K | 125 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: United States held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: ZYDUS LIFESCIENCES LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import bisacodyl from India, how much they buy, and who supplies each market
KEY TAKEAWAY
United Kingdom absorbs 30.3% of India’s 2025-Q4 bisacodyl trade ($196.0K). Beyond the top 10 destinations, 40 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 16 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 40 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much bisacodyl India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$67K
10.4% of trade
8 countries · 20 shipments
Europe
$233K
36.0% of trade
3 countries · 13 shipments
Americas
$157K
24.3% of trade
10 countries · 33 shipments
Africa
$86K
13.2% of trade
16 countries · 48 shipments
Oceania
$104K
16.1% of trade
4 countries · 11 shipments
Fig 4.1 United Kingdom is the #1 corridor ($196K) — 30 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian bisacodyl it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | United Kingdom | $196K | 8 | DRREDDYS LABORATORIES LTD | $132K | S KANT HEALTHCARE LTD | $44K | IND SWIFT LTD | $20K |
| 2 | United States | $93K | 5 | ELYSIUM PHARMACEUTICALS LTD | $55K | TRUECARE BIOMEDIX | $29K | OCEAN HEALTHCARE PVT LTD | $9K |
| 3 | Australia | $80K | 6 | MEDREICH LTD | $75K | PROSFORA TECHNOLOGIES PVT LTD | $5K | — | — |
| 4 | Venezuela | $52K | 7 | LUCENT BIOTECH LTD | $45K | RHOMBUS PHARMA PVT LTD | $7K | — | — |
| 5 | Sri Lanka | $37K | 6 | ZYDUS LIFESCIENCES LTD | $32K | FREDUN PHARMACEUTICALS LTD | $5K | — | — |
| 6 | Netherlands | $37K | 4 | AUROBINDO PHARMA LTD | $37K | RUCHA ENTERPRISES | $7 | — | — |
| 7 | Uganda | $27K | 3 | NEM LABORATORIES PVT LTD | $13K | CENTURION LABORATORIES PVT LTD | $10K | INFUGEN PHARMA PVT LTD | $4K |
| 8 | New Zealand | $24K | 2 | MEDREICH LTD | $24K | — | — | — | — |
| 9 | Tajikistan | $14K | 2 | EVOLET HEALTHCARE PVT LTD | $14K | — | — | — | — |
| 10 | Turkey | $14K | 2 | LABORATE PHARMACEUTICALS INDIA LTD | $9K | MARKSANS PHARMA LTD | $5K | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 10.4% of USD — but United Kingdom is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
30.3%
#1 country share
United Kingdom alone
70.7%
Top 5 share
5 of 41 countries
96.8%
Top 15 share
Long tail of 26 countries = 3.2%
HHI 1460
Destination HHI
Competitive spread
41
Countries served
Global pharma reach from India
16
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
54 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
DRREDDYS LABORATORIES LTD ($131.6K, 20.3% share) and MEDREICH LTD ($98.8K) together control 35.6% of India’s 2025-Q4 bisacodyl trade. The top 5 suppliers hold 57.8%. 54 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian bisacodyl suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 DRREDDYS LABORATORIES LTD leads by $33K over MEDREICH LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: JUVENCIA LIFESCIENCES PVT is #20 by value but #7 by volume.
Fig 5.2 MEDREICH LTD also leads by shipment count (7) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: JUVENCIA LIFESCIENCES PVT moves from #7 by volume to #20 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 54 bisacodyl suppliers split into strategic segments
KEY TAKEAWAY
14 suppliers (25%) generate 85.3% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 DRREDDYS LABORATORIES LTD and MEDREICH LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 85.3% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | EVOLET HEALTHCARE PVT LTD | 2 | 1 | $14K |
| 2 | JUVENCIA LIFESCIENCES PVT LTD | 2 | 1 | $7K |
| 3 | DRREDDYS LABORATORIES LTD | 1 | 1 | $132K |
| 4 | MEDREICH LTD | 1 | 2 | $99K |
| 5 | ELYSIUM PHARMACEUTICALS LTD | 1 | 1 | $55K |
| 6 | LUCENT BIOTECH LTD | 1 | 1 | $45K |
| 7 | S KANT HEALTHCARE LTD | 1 | 1 | $44K |
| 8 | AUROBINDO PHARMA LTD | 1 | 2 | $37K |
| 9 | ZYDUS LIFESCIENCES LTD | 1 | 1 | $32K |
| 10 | TRUECARE BIOMEDIX | 1 | 1 | $29K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the bisacodyl manufacturing hubs
KEY TAKEAWAY
Medchel Malkajgiri Dist and Bengaluru together account for $218K of India’s 2025-Q4 bisacodyl trade.
Fig 5.5 Medchel Malkajgiri Dist (1 exporters, $132K) and Bengaluru (1 exporters, $87K) are India’s bisacodyl capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
57.8%
Top 5 share
5 of 54 suppliers
78.3%
Top 10 share
10 of 54 suppliers
85.3%
Top 25% share
14 suppliers = 85% USD
HHI 932
Supplier HHI
Competitive
54
Total suppliers
shipped Bisacodyl in 2025-Q4
20+ cities
Indian hubs
Medchel Malkajgiri Dist and Bengaluru lead
§5.2 Coming next: 1 exporter deep-dive profiles
Each of the top 1 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | MEDREICH LTD | $99K |
#2
2025-Q4 USD
$99K
15.3% market share
SHIPMENTS
7
avg $14K/ship
COUNTRIES
2
destination markets
BUYERS
3
2 single-sourced
BRANDED
57%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Australia is the #1 market at $75K (76% of trade), followed by New Zealand at $24K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Australia | $75K | 5 | 75.6% |
| 2 | New Zealand | $24K | 2 | 24.4% |
MONTHLY TREND
Nov peaked at $75K. Oct was the weakest at $0.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| MEDREICH AUSTRALIA PTY… | Australia | $75K | ⚠ Locked |
| VIATRIS NEW ZEALAND | New Zealand | $12K | ⚠ Locked |
| Undisclosed buyer | New Zealand | $12K | N/A |
#2
EXPORTER PROFILE #1 OF 1 — TRADE FLOW MAP
MEDREICH LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P1.3 Australia absorbs $75K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
43 importers across 41 countries — who is buying Indian bisacodyl and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 79.3% of total USD. 93% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian bisacodyl. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 MOVIANTO UK LTD is the #1 importer at $132K (20.3%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
93%
Single-source
40 buyers rely on exactly 1 Indian supplier
2%
Dual-source
1 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
5%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source bisacodyl from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Seychelles 4 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| PRISM INTERNATIONAL LLC | MEDMALL PHARMACY PVT… | $28.471 | $0.105 | Tablet |
| MINISTRY OF HEALTH | HLL LIFECARE LTD | $11.980 | $0.0010 | Tablet |
| TO THE INVOICE RAISED … | DRIVECURE HEALTHCARE… | $9.955 | $0.092 | Tablet |
| GOOD HEALTH (PTY) LTD | AL-SUPREME EXPORTS | $0.159 | $0.0053 | Suppository |
United Kingdom 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MOVIANTO UK LTD | DRREDDYS LABORATORIE… | $132K | $0.012 | Tablet |
| GENESIS PHARMACEUTICAL… | IND SWIFT LTD | $20K | $0.017 | Tablet |
Australia 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MEDREICH AUSTRALIA PTY… | MEDREICH LTD | $75K | $0.966 | Tablet |
| NEO HEALTH (OTC) PTY LTD | PROSFORA TECHNOLOGIE… | $5K | $1.417 | Tablet |
Sri Lanka 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| HEMAS PHARMACEUTICALS … | ZYDUS LIFESCIENCES LTD | $32K | $0.118 | Suppository |
| GEORGE STEUART HEALTH … | FREDUN PHARMACEUTICA… | $5K | $0.0049 | Tablet |
Uganda 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| RENE PHARMACY LTD | NEM LABORATORIES PVT… | $13K | $217.987 | Tablet |
| BIOGEN PHARMA LTD | CENTURION LABORATORI… | $10K | $0.514 | Tablet |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | MOVIANTO UK LTD | United Kingdom | $132K | $22K | Mid |
| 2 | MEDREICH AUSTRALIA P… | Australia | $75K | $15K | Budget |
| 3 | HHH PHARMACEUTICALS | United States | $64K | $32K | Mid |
| 4 | AUROBINDO PHARMA B.V | Netherlands | $37K | $37K | Premium |
| 5 | HEMAS PHARMACEUTICAL… | Sri Lanka | $32K | $8K | Budget |
| 6 | STRIVE PHARMACEUTICA… | United States | $29K | $14K | Budget |
| 7 | GENESIS PHARMACEUTIC… | United Kingdom | $20K | $20K | Mid |
| 8 | MADAD PHARM LLC | Tajikistan | $14K | $7K | Budget |
| 9 | RENE PHARMACY LTD | Uganda | $13K | $13K | Budget |
| 10 | ADCOCK INGRAM LTD | South Africa | $12K | $12K | Budget |
| 11 | VIATRIS NEW ZEALAND | New Zealand | $12K | $12K | Budget |
| 12 | BIOGEN PHARMA LTD | Uganda | $10K | $10K | Budget |
| 13 | GITTOES PHARMACEUTIC… | Kenya | $10K | $5K | Budget |
| 14 | MEDICO PLUS | DR Congo | $7K | $2K | Budget |
| 15 | LABORATORIO QUIM-FAR… | Venezuela | $7K | $7K | Budget |
| 16 | PRINCE FARMA SA | Angola | $6K | $3K | Budget |
| 17 | GEORGE STEUART HEALT… | Sri Lanka | $5K | $3K | Budget |
| 18 | NEO HEALTH (OTC) PTY… | Australia | $5K | $5K | Budget |
| 19 | ORGANO COMPANY FOR T… | Turkey | $5K | $5K | Budget |
| 20 | KARIMED PHARMACEUTIC… | Trinidad and Tobago | $5K | $5K | Budget |
| 21 | ACE HEALTH CARE LDA | Mozambique | $4K | $4K | Budget |
| 22 | STE PRINCE PHARMA SARL | DR Congo | $3K | $2K | Budget |
| 23 | T.CHOITHRAM & SONS (… | Liberia | $3K | $3K | Budget |
| 24 | SBR GROUP OF COMPANIES | Liberia | $1K | $1K | Budget |
| 25 | UBSA PHARMA INDUSTRI… | Lebanon | $1K | $1K | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 DRREDDYS LABORATORIES LTD → MOVIANTO UK LTD is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian bisacodyl prices vary by supplier, country and dosage form
KEY TAKEAWAY
Bisacodyl prices span 155044× ($0.0014 → $217.99). The coefficient of variation is 8.39. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0014 | Lowest observed unit price |
| P5 | $0.0023 | 5th percentile |
| P25 | $0.020 | 25th percentile (Q1) |
| Median | $0.155 | 50th percentile (Q2) |
| P75 | $0.443 | 75th percentile (Q3) |
| P95 | $3.44 | 95th percentile |
| Max | $217.99 | Highest observed unit price |
| Mean | $2.37 | Arithmetic average |
| CV | 839% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 NEM LABORATORIES PVT LTD prices at $217.99/unit vs market median $0.155.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. DRREDDYS LABORATORIES LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. MEDREICH LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. S KANT HEALTHCARE Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. NEM LABORATORIES PVT Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | ELYSIUM PHARMACE… | United States | Tablet | 35 | $55K | $2K | Specialty / small-batch |
| Oct 2025 | NEM LABORATORIES… | Uganda | Tablet | 60 | $13K | $217.99 | Specialty / small-batch |
| Nov 2025 | MDS ENTERPRISES | Ghana | Suppository | 30 | $158.77 | $5.29 | Specialty / small-batch |
| Nov 2025 | MDS ENTERPRISES | Ghana | Suppository | 10 | $46.82 | $4.68 | Specialty / small-batch |
| Dec 2025 | SUNNY PHARMA | Montserrat | Tablet | 7 | $29.04 | $4.15 | Specialty / small-batch |
| Dec 2025 | JUVENCIA LIFESCI… | Guyana | Tablet | 1K | $4K | $3.80 | Specialty / small-batch |
| Dec 2025 | JUVENCIA LIFESCI… | Guyana | Tablet | 540 | $2K | $3.75 | Specialty / small-batch |
| Dec 2025 | VEA IMPEX (I) PV… | Seychelles | Suppository | 24 | $81.70 | $3.40 | Specialty / small-batch |
| Dec 2025 | VEA IMPEX (I) PV… | Seychelles | Suppository | 60 | $155.64 | $2.59 | Specialty / small-batch |
| Dec 2025 | AZKA MEDTRADE AN… | Somalia | Tablet | 50 | $107.60 | $2.15 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | NAMAN GLOBAL IMP… | Seychelles | Tablet | 270 | $0.380 | $0.0014 | Bulk generic tablet |
| Dec 2025 | VIDACARE MEDICA … | DR Congo | Tablet | 1.0M | $2K | $0.0015 | Bulk generic tablet |
| Dec 2025 | VIDACARE MEDICA … | DR Congo | Tablet | 1.0M | $2K | $0.0015 | Bulk generic tablet |
| Oct 2025 | TRUECARE BIOMEDIX | United States | Tablet | 7.2M | $14K | $0.0020 | Bulk generic tablet |
| Dec 2025 | TRUECARE BIOMEDIX | United States | Tablet | 7.2M | $15K | $0.0020 | Bulk generic tablet |
| Dec 2025 | AXELIA | DR Congo | Tablet | 4K | $8.20 | $0.0020 | Bulk generic tablet |
| Dec 2025 | VEA IMPEX (I) PV… | Oman | Tablet | 603 | $1.37 | $0.0023 | Bulk generic tablet |
| Nov 2025 | HIRAL LABS LTD | Lebanon | Tablet | 403K | $1K | $0.0029 | Bulk generic tablet |
| Nov 2025 | VIDACARE MEDICA … | Angola | Tablet | 580K | $2K | $0.0030 | Bulk generic tablet |
| Oct 2025 | VIDACARE MEDICA … | Angola | Tablet | 1.5M | $5K | $0.0030 | Bulk generic tablet |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship bisacodyl, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Bisacodyl leaves India through 15+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), BANGALORE AIR, MUNDRA SEA) handle 93.2% of total USD. SEA moves 39% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $229K — top 15 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 LONDON - HEATHROW is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 39% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$372K
57.4% of USD · 39.2% of ships
AIR
$188K
29.1% of USD · 51.2% of ships
ICD
$88K
13.5% of USD · 9.6% of ships
Fig 8.3 The dominant corridor is BANGALORE AIR → Air → Europe ($132K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Cayman Islands is the most concentrated destination (HHI 10000, 1 suppliers). Uganda is the most competitive (HHI 3918).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Cayman Islands (HHI 10,000) is the most concentrated — Uganda (HHI 3,918) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| MOVIANTO UK LTD | United Kingdom | DRREDDYS LABORAT… | $132K | 6 | HIGH |
| MEDREICH AUSTRALIA P… | Australia | MEDREICH LTD | $75K | 5 | MEDIUM |
| AUROBINDO PHARMA B.V | Netherlands | AUROBINDO PHARMA… | $37K | 1 | MEDIUM |
| HEMAS PHARMACEUTICAL… | Sri Lanka | ZYDUS LIFESCIENC… | $32K | 4 | MEDIUM |
| STRIVE PHARMACEUTICA… | United States | TRUECARE BIOMEDIX | $29K | 2 | MEDIUM |
| GENESIS PHARMACEUTIC… | United Kingdom | IND SWIFT LTD | $20K | 1 | MEDIUM |
| MADAD PHARM LLC | Tajikistan | EVOLET HEALTHCAR… | $14K | 2 | MEDIUM |
| RENE PHARMACY LTD | Uganda | NEM LABORATORIES… | $13K | 1 | MEDIUM |
Conclusion: 40 buyers depend on exactly one Indian supplier, representing $452K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| United Kingdom | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| United States | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Australia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Venezuela | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Sri Lanka | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Netherlands | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Uganda | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| New Zealand | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Tajikistan | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Turkey | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| DR Congo | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| South Africa | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Guyana | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Angola | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 10 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in United Kingdom | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Cayman Islands lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter United States (4 suppliers) | This Q | HIGH |
| A6 | Enter Australia (2 suppliers) | This Q | MED |
| A8 | Build United States distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for United Kingdom tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | United States | Other | 4 | $93K | +393.8% | LOW | Growing 394% with only 4 competitors |
| 2 | Australia | Other | 2 | $80K | +356% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | United Kingdom | Other | 3 | $196K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 4 | Sri Lanka | Asia | 2 | $37K | +282.5% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Venezuela | Other | 2 | $52K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Netherlands | Other | 2 | $37K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Uganda | Africa | 3 | $27K | -100% | LOW | Low competition (3 suppliers), accessible market |
| 8 | New Zealand | Other | 1 | $24K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Kenya | Africa | 2 | $14K | +11.4% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Tajikistan | Asia | 1 | $14K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Turkey | Other | 2 | $14K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | DR Congo | Africa | 2 | $12K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | South Africa | Africa | 1 | $12K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Guyana | Other | 3 | $7K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 15 | Angola | Africa | 2 | $7K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 125 2025-Q4 Bisacodyl shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/bisacodyl
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 125 2025-Q4 bisacodyl shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian bisacodyl shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
125
across all regions
TOTAL USD
$647K
2025-Q4 FOB value
UNITS
40.7M
tablets, capsules, etc.
SUPPLIERS
54
Indian exporters
BUYERS
43
global importers
COUNTRIES
41
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $86K (13.2%), spanning 16 countries.
54 Indian suppliers shipped to 43 buyers across 41 countries — average shipment value $5K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
16 countries · 48 shipments · $86K · 23 Indian suppliers · 18 buyers
SHIPMENTS
48
USD
$86K
COUNTRIES
16
SUPPLIERS
23
BUYERS
18
HHI
1,089
competitive
Top 16 destination countries in Africa
1
Uganda (31.9%)
$27K
2
Kenya (16.0%)
$14K
3
DR Congo (14.5%)
$12K
4
South Africa (14.4%)
$12K
5
Angola (7.7%)
$7K
6
Mozambique (4.7%)
$4K
7
Liberia (4.5%)
$4K
8
Gambia (3.3%)
$3K
9
Zambia (1.2%)
$995.63
10
Djibouti (0.5%)
$417.80
11
Seychelles (0.5%)
$399.76
12
Guinea-Bissau (0.3%)
$216.74
13
Ghana (0.2%)
$205.59
14
Burkina Faso (0.2%)
$173.57
15
Somalia (0.1%)
$107.60
16
Zimbabwe (0.0%)
$1.63
Top 23 Indian suppliers into Africa
1
NEM LABORATORIES PVT LTD
$13K
2
ADCOCK INGRAM LTD
$12K
3
CENTURION LABORATORIES PVT LTD
$10K
4
AGOG PHARMA LTD
$10K
5
AXELIA
$9K
6
VIDACARE MEDICA PVT LTD
$9K
7
INFUGEN PHARMA PVT LTD
$8K
8
BIOMATRIX HEALTHCARE PVT LTD
$4K
9
SAVORITE PHARMACEUTICALS PVT LTD
$3K
10
FOURRTS (INDIA) LABORATORIES PVT LTD
$3K
11
BHUMI PHARMACEUTICALS
$1K
12
PATSONS INTERNATIONAL
$995.63
13
DRIVECURE HEALTHCARE PVT LTD
$352.83
14
VEA IMPEX (I) PVT LTD
$348.82
15
TRIDENT IMPEX
$216.74
16
MDS ENTERPRISES
$205.59
17
SANSKRUTI PHARMA
$173.57
18
AZKA MEDTRADE AND SERVICES
$107.60
19
MEDMALL PHARMACY PVT LTD
$28.47
20
HLL LIFECARE LTD
$11.98
21
RUTVA MEDICARE
$1.63
22
NAMAN GLOBAL IMPEX PVT LTD
$0.380
23
AL-SUPREME EXPORTS
$0.159
Top 16 Africa importers
1
RENE PHARMACY LTD · Uganda
$13K
2
ADCOCK INGRAM LTD · South Africa
$12K
3
BIOGEN PHARMA LTD · Uganda
$10K
4
GITTOES PHARMACEUTICALS LTD · Kenya
$10K
5
MEDICO PLUS · DR Congo
$7K
6
PRINCE FARMA SA · Angola
$6K
7
ACE HEALTH CARE LDA · Mozambique
$4K
8
STE PRINCE PHARMA SARL · DR Congo
$3K
9
T.CHOITHRAM & SONS (LIB) INC · Liberia
$3K
10
SBR GROUP OF COMPANIES · Liberia
$1K
11
LUSAKA PHARMACEUTICALS LTD · Zambia
$995.63
12
ALLIANCE PHARMA SARL · Guinea-Bissau
$216.74
13
PRISM INTERNATIONAL LLC · Seychelles
$28.47
14
MINISTRY OF HEALTH · Seychelles
$11.98
15
TO THE INVOICE RAISED TO MANGER OF · Seychelles
$9.95
16
GOOD HEALTH (PTY) LTD · Seychelles
$0.159
Top 2 dosage forms
1
Tablet
$85K
2
Suppository
$461.93
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 9 | $40K | $4K |
| Nov | 13 | $13K | $993.94 |
| Dec | 26 | $33K | $1K |
Shipment register · 48 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — NEM LABORATORIES PVT LTD · 1 shipments · $13K | |||||||||||
| 1 | Oct 2025 | RENE PHARMACY LTD | Uganda | Tablet | 60 | NOS | $217.99 | $13K | NHAVA SHEVA SEA (JNPT) | Kampala | SEA |
| SUPPLIER #2 — ADCOCK INGRAM LTD · 1 shipments · $12K | |||||||||||
| 2 | Dec 2025 | ADCOCK INGRAM LTD | South Africa | Tablet | 121.1K | NOS | $0.102 | $12K | BANGALORE ICD | DURBAN | ICD |
| SUPPLIER #3 — CENTURION LABORATORIES PVT LTD · 1 shipments · $10K | |||||||||||
| 3 | Oct 2025 | BIOGEN PHARMA LTD | Uganda | Tablet | 19.8K | NOS | $0.514 | $10K | MUNDRA SEA | MOMBASA | SEA |
| SUPPLIER #4 — AGOG PHARMA LTD · 2 shipments · $10K | |||||||||||
| 4 | Nov 2025 | GITTOES PHARMACEUTICALS LTD | Kenya | Tablet | 13.5K | NOS | $0.389 | $5K | NHAVA SHEVA SEA (JNPT) | Mombasa | SEA |
| 5 | Dec 2025 | GITTOES PHARMACEUTICALS LTD | Kenya | Tablet | 11.3K | NOS | $0.390 | $4K | NHAVA SHEVA SEA (JNPT) | Mombasa | SEA |
| SUPPLIER #5 — AXELIA · 5 shipments · $9K | |||||||||||
| 6 | Nov 2025 | MEDICO PLUS | DR Congo | Tablet | 12.0K | NOS | $0.180 | $2K | NHAVA SHEVA SEA (JNPT) | Matadi | SEA |
| 7 | Nov 2025 | UNKNOWN BUYER | DR Congo | Tablet | 12.0K | NOS | $0.180 | $2K | NHAVA SHEVA SEA (JNPT) | Matadi | SEA |
| 8 | Dec 2025 | MEDICO PLUS | DR Congo | Tablet | 13.6K | NOS | $0.184 | $3K | NHAVA SHEVA SEA (JNPT) | Matadi | SEA |
| 9 | Dec 2025 | MEDICO PLUS | DR Congo | Tablet | 4.0K | NOS | $0.0020 | $8.20 | NHAVA SHEVA SEA (JNPT) | Dar Es Salaam | SEA |
| 10 | Dec 2025 | MEDICO PLUS | DR Congo | Tablet | 13.8K | NOS | $0.184 | $3K | NHAVA SHEVA SEA (JNPT) | Matadi | SEA |
| SUPPLIER #6 — VIDACARE MEDICA PVT LTD · 4 shipments · $9K | |||||||||||
| 11 | Oct 2025 | PRINCE FARMA SA | Angola | Tablet | 1.5M | NOS | $0.0030 | $5K | NHAVA SHEVA SEA (JNPT) | Luanda | SEA |
| 12 | Nov 2025 | PRINCE FARMA SA | Angola | Tablet | 580.0K | NOS | $0.0030 | $2K | NHAVA SHEVA SEA (JNPT) | Luanda | SEA |
| 13 | Dec 2025 | STE PRINCE PHARMA SARL | DR Congo | Tablet | 1.0M | NOS | $0.0015 | $2K | NHAVA SHEVA SEA (JNPT) | Matadi | SEA |
| 14 | Dec 2025 | STE PRINCE PHARMA SARL | DR Congo | Tablet | 1.0M | NOS | $0.0015 | $2K | NHAVA SHEVA SEA (JNPT) | Matadi | SEA |
| SUPPLIER #7 — INFUGEN PHARMA PVT LTD · 2 shipments · $8K | |||||||||||
| 15 | Oct 2025 | UNLISTED BUYER | Kenya | Tablet | 10.0K | NOS | $0.396 | $4K | NHAVA SHEVA SEA (JNPT) | Kampala | SEA |
| 16 | Oct 2025 | UNLISTED BUYER | Uganda | Tablet | 10.0K | NOS | $0.396 | $4K | NHAVA SHEVA SEA (JNPT) | Kampala | SEA |
| SUPPLIER #8 — BIOMATRIX HEALTHCARE PVT LTD · 4 shipments · $4K | |||||||||||
| 17 | Dec 2025 | UNLISTED BUYER | Djibouti | Tablet | 7.6K | NOS | $0.018 | $133.64 | NHAVA SHEVA SEA (JNPT) | Djibouti | SEA |
| 18 | Dec 2025 | UNLISTED BUYER | Djibouti | Tablet | 7.5K | NOS | $0.018 | $132.24 | NHAVA SHEVA SEA (JNPT) | Djibouti | AIR |
| 19 | Dec 2025 | UNLISTED BUYER | Djibouti | Tablet | 7.6K | NOS | $0.020 | $151.92 | NHAVA SHEVA SEA (JNPT) | Djibouti | SEA |
| 20 | Dec 2025 | ACE HEALTH CARE LDA | Mozambique | Tablet | 7.2K | TBS | $0.563 | $4K | AHMEDABAD ICD | MAPUTO | ICD |
| SUPPLIER #9 — SAVORITE PHARMACEUTICALS PVT LTD · 2 shipments · $3K | |||||||||||
| 21 | Dec 2025 | UNLISTED BUYER | Gambia | Tablet | 5.1K | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Banjul | SEA |
| 22 | Dec 2025 | UNLISTED BUYER | Gambia | Tablet | 5.1K | NOS | $0.559 | $3K | NHAVA SHEVA SEA (JNPT) | Banjul | SEA |
| SUPPLIER #10 — FOURRTS (INDIA) LABORATORIES PVT LTD · 1 shipments · $3K | |||||||||||
| 23 | Oct 2025 | T.CHOITHRAM & SONS (LIB) INC | Liberia | Tablet | 5.9K | NOS | $0.426 | $3K | ENNORE SEA | Monrovia | SEA |
| SUPPLIER #11 — BHUMI PHARMACEUTICALS · 1 shipments · $1K | |||||||||||
| 24 | Oct 2025 | SBR GROUP OF COMPANIES | Liberia | Tablet | 3.0K | NOS | $0.445 | $1K | AHMEDABAD ICD | Monrovia | ICD |
| SUPPLIER #12 — PATSONS INTERNATIONAL · 1 shipments · $995.63 | |||||||||||
| 25 | Nov 2025 | LUSAKA PHARMACEUTICALS LTD | Zambia | Tablet | 10.0K | NOS | $0.100 | $995.63 | AHMEDABAD AIR | LUSAKA | AIR |
| SUPPLIER #13 — DRIVECURE HEALTHCARE PVT LTD · 2 shipments · $352.83 | |||||||||||
| 26 | Oct 2025 | UNLISTED BUYER | Angola | Tablet | 940 | NOS | $0.365 | $342.88 | NHAVA SHEVA SEA (JNPT) | Luanda | SEA |
| 27 | Nov 2025 | TO THE INVOICE RAISED TO MANGER OF | Seychelles | Tablet | 108 | NOS | $0.092 | $9.95 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR |
| SUPPLIER #14 — VEA IMPEX (I) PVT LTD · 9 shipments · $348.82 | |||||||||||
| 28 | Dec 2025 | UNLISTED BUYER | Seychelles | Tablet | 90 | NOS | $0.146 | $13.14 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR |
| 29 | Dec 2025 | UNLISTED BUYER | Seychelles | Suppository | 24 | NOS | $3.40 | $81.70 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR |
| 30 | Dec 2025 | UNLISTED BUYER | Seychelles | Tablet | 450 | NOS | $0.157 | $70.65 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR |
| 31 | Dec 2025 | UNLISTED BUYER | Seychelles | Suppository | 60 | NOS | $2.59 | $155.64 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR |
| 32 | Dec 2025 | UNLISTED BUYER | Seychelles | Suppository | 30 | NOS | $0.628 | $18.84 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR |
| 33 | Dec 2025 | UNLISTED BUYER | Seychelles | Tablet | 27 | NOS | $0.146 | $3.94 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR |
| 34 | Dec 2025 | UNLISTED BUYER | Seychelles | Tablet | 3 | NOS | $0.147 | $0.440 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR |
| 35 | Dec 2025 | UNLISTED BUYER | Seychelles | Tablet | 27 | NOS | $0.149 | $4.02 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR |
| 36 | Dec 2025 | UNLISTED BUYER | Seychelles | Tablet | 3 | NOS | $0.150 | $0.449 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR |
| SUPPLIER #15 — TRIDENT IMPEX · 1 shipments · $216.74 | |||||||||||
| 37 | Nov 2025 | ALLIANCE PHARMA SARL | Guinea-Bissau | Tablet | 200 | NOS | $1.08 | $216.74 | NHAVA SHEVA SEA (JNPT) | Dakar | SEA |
| SUPPLIER #16 — MDS ENTERPRISES · 2 shipments · $205.59 | |||||||||||
| 38 | Nov 2025 | UNLISTED BUYER | Ghana | Suppository | 30 | NOS | $5.29 | $158.77 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 39 | Nov 2025 | UNLISTED BUYER | Ghana | Suppository | 10 | NOS | $4.68 | $46.82 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #17 — SANSKRUTI PHARMA · 3 shipments · $173.57 | |||||||||||
| 40 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Tablet | 400 | NOS | $0.148 | $59.38 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 41 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Tablet | 400 | NOS | $0.143 | $57.09 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 42 | Nov 2025 | UNKNOWN BUYER | Burkina Faso | Tablet | 400 | NOS | $0.143 | $57.09 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| SUPPLIER #18 — AZKA MEDTRADE AND SERVICES · 1 shipments · $107.60 | |||||||||||
| 43 | Dec 2025 | UNLISTED BUYER | Somalia | Tablet | 50 | NOS | $2.15 | $107.60 | MUMBAI AIR (SAHAR) | MOGADISCHU | AIR |
| SUPPLIER #19 — MEDMALL PHARMACY PVT LTD · 1 shipments · $28.47 | |||||||||||
| 44 | Oct 2025 | PRISM INTERNATIONAL LLC | Seychelles | Tablet | 270 | NOS | $0.105 | $28.47 | HYDERABAD AIR | MAHE ISLAND | AIR |
| SUPPLIER #20 — HLL LIFECARE LTD · 1 shipments · $11.98 | |||||||||||
| 45 | Nov 2025 | MINISTRY OF HEALTH | Seychelles | Tablet | 12.0K | NOS | $0.0010 | $11.98 | DELHI AIR | MAHE ISLAND | AIR |
| SUPPLIER #21 — RUTVA MEDICARE · 1 shipments · $1.63 | |||||||||||
| 46 | Dec 2025 | UNLISTED BUYER | Zimbabwe | Tablet | 80 | PCS | $0.020 | $1.63 | AHMEDABAD AIR | HARARE | AIR |
| SUPPLIER #22 — NAMAN GLOBAL IMPEX PVT LTD · 1 shipments · $0.380 | |||||||||||
| 47 | Dec 2025 | UNKNOWN BUYER | Seychelles | Tablet | 270 | NOS | $0.0014 | $0.380 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR |
| SUPPLIER #23 — AL-SUPREME EXPORTS · 1 shipments · $0.159 | |||||||||||
| 48 | Dec 2025 | GOOD HEALTH (PTY) LTD | Seychelles | Suppository | 30 | NOS | $0.0053 | $0.159 | CHENNAI AIR | MAHE ISLAND | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
8 countries · 20 shipments · $67K · 12 Indian suppliers · 9 buyers
SHIPMENTS
20
USD
$67K
COUNTRIES
8
SUPPLIERS
12
BUYERS
9
HHI
2,987
concentrated
Top 8 destination countries in Asia
1
Sri Lanka (55.3%)
$37K
2
Tajikistan (21.2%)
$14K
3
Turkey (20.9%)
$14K
4
Lebanon (1.8%)
$1K
5
Afghanistan (0.8%)
$529.39
6
Singapore (0.1%)
$39.98
7
United Arab Emirates (0.0%)
$3.61
8
Oman (0.0%)
$1.37
Top 12 Indian suppliers into Asia
1
ZYDUS LIFESCIENCES LTD
$32K
2
EVOLET HEALTHCARE PVT LTD
$14K
3
LABORATE PHARMACEUTICALS INDIA LTD
$9K
4
FREDUN PHARMACEUTICALS LTD
$5K
5
MARKSANS PHARMA LTD
$5K
6
HIRAL LABS LTD
$1K
7
KERK
$529.39
8
SANITAS MEDTECH INSTITUTE PVT LTD
$36.59
9
RUCHA ENTERPRISES
$3.39
10
MDS ENTERPRISES
$2.92
11
VEA IMPEX (I) PVT LTD
$1.37
12
MOVID IMPEX
$0.693
Top 8 Asia importers
1
HEMAS PHARMACEUTICALS (PVT) LTD · Sri Lanka
$32K
2
MADAD PHARM LLC · Tajikistan
$14K
3
GEORGE STEUART HEALTH PVT LTD · Sri Lanka
$5K
4
ORGANO COMPANY FOR TRADING PHARMACE · Turkey
$5K
5
UBSA PHARMA INDUSTRIES S.A · Lebanon
$1K
6
MUBARAK HASHIMI LTD · Afghanistan
$529.39
7
SUCCESS INTER LINK PTE LTD · Singapore
$36.59
8
EMIRATES POST GROUP · United Arab Emirates
$0.693
Top 2 dosage forms
1
Suppository
$42K
2
Tablet
$25K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 4 | $22K | $5K |
| Nov | 5 | $15K | $3K |
| Dec | 11 | $30K | $3K |
Shipment register · 20 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ZYDUS LIFESCIENCES LTD · 4 shipments · $32K | |||||||||||
| 1 | Oct 2025 | HEMAS PHARMACEUTICALS (PVT) LTD | Sri Lanka | Suppository | 3.5K | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 2 | Oct 2025 | HEMAS PHARMACEUTICALS (PVT) LTD | Sri Lanka | Suppository | 71.8K | NOS | $0.108 | $8K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 3 | Dec 2025 | HEMAS PHARMACEUTICALS (PVT) LTD | Sri Lanka | Suppository | 50.4K | NOS | $0.123 | $6K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 4 | Dec 2025 | HEMAS PHARMACEUTICALS (PVT) LTD | Sri Lanka | Suppository | 144.9K | NOS | $0.124 | $18K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| SUPPLIER #2 — EVOLET HEALTHCARE PVT LTD · 2 shipments · $14K | |||||||||||
| 5 | Nov 2025 | MADAD PHARM LLC | Tajikistan | Tablet | 68.4K | NOS | $0.138 | $9K | NHAVA SHEVA SEA (JNPT) | Dushanbe | SEA |
| 6 | Nov 2025 | MADAD PHARM LLC | Tajikistan | Suppository | 20.3K | NOS | $0.238 | $5K | NHAVA SHEVA SEA (JNPT) | Dushanbe | SEA |
| SUPPLIER #3 — LABORATE PHARMACEUTICALS INDIA LTD · 1 shipments · $9K | |||||||||||
| 7 | Oct 2025 | UNLISTED BUYER | Turkey | Tablet | 29.6K | NOS | $0.301 | $9K | PATLI ICD | ISKENDERUN | ICD |
| SUPPLIER #4 — FREDUN PHARMACEUTICALS LTD · 2 shipments · $5K | |||||||||||
| 8 | Dec 2025 | GEORGE STEUART HEALTH PVT LTD | Sri Lanka | Tablet | 1.1M | NOS | $0.0049 | $5K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 9 | Dec 2025 | GEORGE STEUART HEALTH PVT LTD | Sri Lanka | Tablet | 1 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| SUPPLIER #5 — MARKSANS PHARMA LTD · 1 shipments · $5K | |||||||||||
| 10 | Oct 2025 | ORGANO COMPANY FOR TRADING PHARMACE | Turkey | Suppository | 15.0K | NOS | $0.347 | $5K | NHAVA SHEVA SEA (JNPT) | Mersin | SEA |
| SUPPLIER #6 — HIRAL LABS LTD · 1 shipments · $1K | |||||||||||
| 11 | Nov 2025 | UBSA PHARMA INDUSTRIES S.A | Lebanon | Tablet | 403.2K | NOS | $0.0029 | $1K | DELHI AIR | BEIRUT | AIR |
| SUPPLIER #7 — KERK · 1 shipments · $529.39 | |||||||||||
| 12 | Dec 2025 | MUBARAK HASHIMI LTD | Afghanistan | Tablet | 3.1K | NOS | $0.170 | $529.39 | TUGHLAKABAD ICD | Kandahar | ICD |
| SUPPLIER #8 — SANITAS MEDTECH INSTITUTE PVT LTD · 1 shipments · $36.59 | |||||||||||
| 13 | Dec 2025 | SUCCESS INTER LINK PTE LTD | Singapore | Tablet | 40 | NOS | $0.915 | $36.59 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #9 — RUCHA ENTERPRISES · 2 shipments · $3.39 | |||||||||||
| 14 | Nov 2025 | UNLISTED BUYER | Singapore | Tablet | 5 | NOS | $0.288 | $1.44 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 15 | Dec 2025 | UNLISTED BUYER | Singapore | Tablet | 6 | NOS | $0.325 | $1.95 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #10 — MDS ENTERPRISES · 3 shipments · $2.92 | |||||||||||
| 16 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Suppository | 20 | NOS | $0.070 | $1.41 | MUMBAI AIR (SAHAR) | SHARJAH | AIR |
| 17 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Suppository | 20 | NOS | $0.061 | $1.22 | MUMBAI AIR (SAHAR) | SHARJAH | AIR |
| 18 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 20 | NOS | $0.015 | $0.294 | MUMBAI AIR (SAHAR) | SHARJAH | AIR |
| SUPPLIER #11 — VEA IMPEX (I) PVT LTD · 1 shipments · $1.37 | |||||||||||
| 19 | Dec 2025 | UNLISTED BUYER | Oman | Tablet | 603 | NOS | $0.0023 | $1.37 | MUMBAI AIR (SAHAR) | MUSCAT | AIR |
| SUPPLIER #12 — MOVID IMPEX · 1 shipments · $0.693 | |||||||||||
| 20 | Nov 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 6 | NOS | $0.115 | $0.693 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
3 countries · 13 shipments · $233K · 5 Indian suppliers · 5 buyers
SHIPMENTS
13
USD
$233K
COUNTRIES
3
SUPPLIERS
5
BUYERS
5
HHI
3,870
concentrated
Top 3 destination countries in Europe
1
United Kingdom (84.0%)
$196K
2
Netherlands (15.9%)
$37K
3
Malta (0.0%)
$11.95
Top 5 Indian suppliers into Europe
1
DRREDDYS LABORATORIES LTD
$132K
2
S KANT HEALTHCARE LTD
$44K
3
AUROBINDO PHARMA LTD
$37K
4
IND SWIFT LTD
$20K
5
RUCHA ENTERPRISES
$6.73
Top 4 Europe importers
1
MOVIANTO UK LTD · United Kingdom
$132K
2
AUROBINDO PHARMA B.V · Netherlands
$37K
3
GENESIS PHARMACEUTICALS LTD · United Kingdom
$20K
4
APL SWIFT SERVICES (MALTA) LTD · Malta
$11.95
Top 1 dosage forms
1
Tablet
$233K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $37K | $19K |
| Nov | 5 | $64K | $13K |
| Dec | 6 | $132K | $22K |
Shipment register · 13 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — DRREDDYS LABORATORIES LTD · 6 shipments · $132K | |||||||||||
| 1 | Dec 2025 | MOVIANTO UK LTD | United Kingdom | Tablet | 2.0M | NOS | $0.014 | $28K | BANGALORE AIR | LONDON - HEATHROW | AIR |
| 2 | Dec 2025 | MOVIANTO UK LTD | United Kingdom | Tablet | 1.5M | NOS | $0.012 | $17K | BANGALORE AIR | LONDON - HEATHROW | AIR |
| 3 | Dec 2025 | MOVIANTO UK LTD | United Kingdom | Tablet | 1.8M | NOS | $0.012 | $21K | BANGALORE AIR | LONDON - HEATHROW | AIR |
| 4 | Dec 2025 | MOVIANTO UK LTD | United Kingdom | Tablet | 2.0M | NOS | $0.014 | $28K | BANGALORE AIR | LONDON - HEATHROW | AIR |
| 5 | Dec 2025 | MOVIANTO UK LTD | United Kingdom | Tablet | 1.5M | NOS | $0.012 | $17K | BANGALORE AIR | LONDON - HEATHROW | AIR |
| 6 | Dec 2025 | MOVIANTO UK LTD | United Kingdom | Tablet | 1.8M | NOS | $0.012 | $21K | BANGALORE AIR | LONDON - HEATHROW | AIR |
| SUPPLIER #2 — S KANT HEALTHCARE LTD · 1 shipments · $44K | |||||||||||
| 7 | Nov 2025 | UNLISTED BUYER | United Kingdom | Tablet | 2.2M | TBS | $0.020 | $44K | NHAVA SHEVA SEA (JNPT) | Southampton | SEA |
| SUPPLIER #3 — AUROBINDO PHARMA LTD · 2 shipments · $37K | |||||||||||
| 8 | Oct 2025 | APL SWIFT SERVICES (MALTA) LTD | Malta | Tablet | 1.5K | NOS | $0.0080 | $11.95 | HYDERABAD AIR | MALTA | AIR |
| 9 | Oct 2025 | AUROBINDO PHARMA B.V | Netherlands | Tablet | 3.4M | NOS | $0.011 | $37K | VIZAG SEA | ROTTERDAM | SEA |
| SUPPLIER #4 — IND SWIFT LTD · 1 shipments · $20K | |||||||||||
| 10 | Nov 2025 | GENESIS PHARMACEUTICALS LTD | United Kingdom | Tablet | 1.2M | NOS | $0.017 | $20K | NHAVA SHEVA SEA (JNPT) | Felixstowe | SEA |
| SUPPLIER #5 — RUCHA ENTERPRISES · 3 shipments · $6.73 | |||||||||||
| 11 | Nov 2025 | UNLISTED BUYER | Netherlands | Tablet | 6 | NOS | $0.297 | $1.78 | MUMBAI AIR (SAHAR) | AMSTERDAM, SCHIPHOL | AIR |
| 12 | Nov 2025 | UNLISTED BUYER | Netherlands | Tablet | 6 | NOS | $0.297 | $1.78 | MUMBAI AIR (SAHAR) | AMSTERDAM, SCHIPHOL | AIR |
| 13 | Nov 2025 | UNLISTED BUYER | Netherlands | Tablet | 8 | NOS | $0.396 | $3.17 | MUMBAI AIR (SAHAR) | AMSTERDAM, SCHIPHOL | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
10 countries · 33 shipments · $157K · 15 Indian suppliers · 10 buyers
SHIPMENTS
33
USD
$157K
COUNTRIES
10
SUPPLIERS
15
BUYERS
10
HHI
2,461
moderate
Top 10 destination countries in Americas
1
United States (58.9%)
$93K
2
Venezuela (33.0%)
$52K
3
Guyana (4.8%)
$7K
4
Trinidad and Tobago (3.1%)
$5K
5
Cayman Islands (0.2%)
$325.37
6
Saint Kitts and Nevis (0.1%)
$145.47
7
Montserrat (0.0%)
$29.04
8
Jamaica (0.0%)
$20.16
9
Panama (0.0%)
$4.41
10
Saint Lucia (0.0%)
$0.061
Top 15 Indian suppliers into Americas
1
ELYSIUM PHARMACEUTICALS LTD
$55K
2
LUCENT BIOTECH LTD
$45K
3
TRUECARE BIOMEDIX
$29K
4
OCEAN HEALTHCARE PVT LTD
$9K
5
JUVENCIA LIFESCIENCES PVT LTD
$7K
6
RHOMBUS PHARMA PVT LTD
$7K
7
BDH INDUSTRIES LTD
$5K
8
NARAYANA HRUDAYALAYA LTD
$325.37
9
FLAGSHIP BIOTECH INTERNATIONAL PVT LTD
$316.41
10
AASHIRWAD PHARMA INTERNATIONAL PVT LTD
$145.47
11
SUNNY PHARMA
$29.04
12
SHARVIK IMPEX (INDIA) PVT LTD
$20.16
13
PEAK HEALTHCARE
$11.38
14
RUCHA ENTERPRISES
$4.44
15
WHITE LOTUS HEALTHCARE
$0.061
Top 8 Americas importers
1
HHH PHARMACEUTICALS · United States
$64K
2
STRIVE PHARMACEUTICALS INC · United States
$29K
3
LABORATORIO QUIM-FAR, C.A · Venezuela
$7K
4
KARIMED PHARMACEUTICALS LTD · Trinidad and Tobago
$5K
5
HEALTH CITY CAYMAN ISLANDS (HCCI) · Cayman Islands
$325.37
6
HEALTH PLUS PHARMACY · Saint Kitts and Nevis
$145.47
7
CENTRAL MEDICAL STORES, MINISTRY OF · Montserrat
$29.04
8
JOAN DAVIS · Jamaica
$20.16
Top 2 dosage forms
1
Tablet
$156K
2
Suppository
$2K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $14K | $14K |
| Nov | 7 | $14K | $2K |
| Dec | 25 | $129K | $5K |
Shipment register · 33 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ELYSIUM PHARMACEUTICALS LTD · 1 shipments · $55K | |||||||||||
| 1 | Dec 2025 | HHH PHARMACEUTICALS | United States | Tablet | 35 | NOS | $2K | $55K | MUNDRA SEA | New York | SEA |
| SUPPLIER #2 — LUCENT BIOTECH LTD · 6 shipments · $45K | |||||||||||
| 2 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 48.2K | NOS | $0.155 | $7K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 3 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 48.2K | NOS | $0.155 | $7K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 4 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 48.2K | NOS | $0.155 | $7K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 5 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 48.2K | NOS | $0.155 | $7K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 6 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 48.2K | NOS | $0.155 | $7K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 7 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 48.2K | NOS | $0.155 | $7K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| SUPPLIER #3 — TRUECARE BIOMEDIX · 2 shipments · $29K | |||||||||||
| 8 | Oct 2025 | STRIVE PHARMACEUTICALS INC | United States | Tablet | 7.2M | NOS | $0.0020 | $14K | MUNDRA SEA | New York | SEA |
| 9 | Dec 2025 | STRIVE PHARMACEUTICALS INC | United States | Tablet | 7.2M | NOS | $0.0020 | $15K | MUNDRA SEA | New York | SEA |
| SUPPLIER #4 — OCEAN HEALTHCARE PVT LTD · 1 shipments · $9K | |||||||||||
| 10 | Nov 2025 | HHH PHARMACEUTICALS | United States | Tablet | 2.3M | NOS | $0.0038 | $9K | CHENNAI SEA | New York | SEA |
| SUPPLIER #5 — JUVENCIA LIFESCIENCES PVT LTD · 3 shipments · $7K | |||||||||||
| 11 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 1.0K | NOS | $3.80 | $4K | AHMEDABAD ICD | GEORGETOWN | ICD |
| 12 | Dec 2025 | UNLISTED BUYER | Guyana | Suppository | 2.0K | NOS | $0.671 | $1K | AHMEDABAD ICD | GEORGETOWN | ICD |
| 13 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 540 | NOS | $3.75 | $2K | AHMEDABAD AIR | GEORGETOWN | AIR |
| SUPPLIER #6 — RHOMBUS PHARMA PVT LTD · 1 shipments · $7K | |||||||||||
| 14 | Dec 2025 | LABORATORIO QUIM-FAR, C.A | Venezuela | Tablet | 20.0K | NOS | $0.347 | $7K | AHMEDABAD ICD | LA GUAIRA | ICD |
| SUPPLIER #7 — BDH INDUSTRIES LTD · 1 shipments · $5K | |||||||||||
| 15 | Nov 2025 | KARIMED PHARMACEUTICALS LTD | Trinidad and Tobago | Tablet | 4.0K | NOS | $1.21 | $5K | NHAVA SHEVA SEA (JNPT) | Port of Spain | SEA |
| SUPPLIER #8 — NARAYANA HRUDAYALAYA LTD · 6 shipments · $325.37 | |||||||||||
| 16 | Nov 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Tablet | 800 | NOS | $0.100 | $79.86 | BANGALORE AIR | GEORGETOWN | AIR |
| 17 | Nov 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Suppository | 120 | NOS | $0.898 | $107.82 | MUMBAI AIR (SAHAR) | GRAND CAYMAN | AIR |
| 18 | Dec 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Suppository | 30 | NOS | $0.918 | $27.54 | BANGALORE AIR | GEORGETOWN | AIR |
| 19 | Dec 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Suppository | 30 | NOS | $0.918 | $27.54 | BANGALORE AIR | GEORGETOWN | AIR |
| 20 | Dec 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Suppository | 20 | NOS | $0.918 | $18.36 | BANGALORE AIR | GEORGETOWN | AIR |
| 21 | Dec 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Suppository | 70 | NOS | $0.918 | $64.25 | BANGALORE AIR | GEORGETOWN | AIR |
| SUPPLIER #9 — FLAGSHIP BIOTECH INTERNATIONAL PVT LTD · 1 shipments · $316.41 | |||||||||||
| 22 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 810 | NOS | $0.391 | $316.41 | MUMBAI AIR (SAHAR) | GEORGETOWN | AIR |
| SUPPLIER #10 — AASHIRWAD PHARMA INTERNATIONAL PVT LTD · 1 shipments · $145.47 | |||||||||||
| 23 | Nov 2025 | HEALTH PLUS PHARMACY | Saint Kitts and Nevis | Tablet | 1.4K | NOS | $0.108 | $145.47 | MUMBAI AIR (SAHAR) | ST KITTS | AIR |
| SUPPLIER #11 — SUNNY PHARMA · 1 shipments · $29.04 | |||||||||||
| 24 | Dec 2025 | CENTRAL MEDICAL STORES, MINISTRY OF | Montserrat | Tablet | 7 | NOS | $4.15 | $29.04 | MUMBAI AIR (SAHAR) | MONTSERRAT | AIR |
| SUPPLIER #12 — SHARVIK IMPEX (INDIA) PVT LTD · 2 shipments · $20.16 | |||||||||||
| 25 | Dec 2025 | JOAN DAVIS | Jamaica | Tablet | 90 | NOS | $0.140 | $12.60 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
| 26 | Dec 2025 | JOAN DAVIS | Jamaica | Tablet | 54 | NOS | $0.140 | $7.56 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
| SUPPLIER #13 — PEAK HEALTHCARE · 3 shipments · $11.38 | |||||||||||
| 27 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 60 | NOS | $0.095 | $5.69 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 28 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 60 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 29 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 60 | NOS | $0.095 | $5.68 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| SUPPLIER #14 — RUCHA ENTERPRISES · 3 shipments · $4.44 | |||||||||||
| 30 | Nov 2025 | UNLISTED BUYER | Panama | Tablet | 5 | NOS | $0.441 | $2.20 | MUMBAI AIR (SAHAR) | PANAMA CITY - | AIR |
| 31 | Nov 2025 | UNKNOWN BUYER | Panama | Tablet | 5 | NOS | $0.441 | $2.20 | MUMBAI AIR (SAHAR) | PANAMA CITY - | AIR |
| 32 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 6 | NOS | $0.0045 | $0.027 | MUMBAI AIR (SAHAR) | HOUSTON, INTERCONTIN | AIR |
| SUPPLIER #15 — WHITE LOTUS HEALTHCARE · 1 shipments · $0.061 | |||||||||||
| 33 | Dec 2025 | UNLISTED BUYER | Saint Lucia | Suppository | 3 | NOS | $0.020 | $0.061 | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
4 countries · 11 shipments · $104K · 4 Indian suppliers · 6 buyers
SHIPMENTS
11
USD
$104K
COUNTRIES
4
SUPPLIERS
4
BUYERS
6
HHI
9,016
concentrated
Top 4 destination countries in Oceania
1
Australia (76.8%)
$80K
2
New Zealand (23.1%)
$24K
3
Nauru (0.1%)
$65.27
4
Papua New Guinea (0.0%)
$14.38
Top 4 Indian suppliers into Oceania
1
MEDREICH LTD
$99K
2
PROSFORA TECHNOLOGIES PVT LTD
$5K
3
HLL LIFECARE LTD
$65.27
4
WORLDWIDE SKY TRADING (INDIA)
$14.38
Top 5 Oceania importers
1
MEDREICH AUSTRALIA PTY LTD · Australia
$75K
2
VIATRIS NEW ZEALAND · New Zealand
$12K
3
NEO HEALTH (OTC) PTY LTD · Australia
$5K
4
REPUBLIC OF NAURU - DEPARTMENT OF H · Nauru
$65.27
5
M/S.CHEMCARE GROUP LTD · Papua New Guinea
$14.38
Top 2 dosage forms
1
Tablet
$104K
2
Suppository
$8.16
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $5K | $5K |
| Nov | 6 | $75K | $12K |
| Dec | 4 | $24K | $6K |
Shipment register · 11 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MEDREICH LTD · 7 shipments · $99K | |||||||||||
| 1 | Nov 2025 | VIATRIS NEW ZEALAND | New Zealand | Tablet | 6.8K | NOS | $1.76 | $12K | BANGALORE ICD | Auckland | ICD |
| 2 | Nov 2025 | UNKNOWN BUYER | New Zealand | Tablet | 6.8K | NOS | $1.76 | $12K | BANGALORE ICD | Auckland | ICD |
| 3 | Nov 2025 | MEDREICH AUSTRALIA PTY LTD | Australia | Tablet | 24.8K | NOS | $0.524 | $13K | BANGALORE AIR | SYDNEY | AIR |
| 4 | Nov 2025 | MEDREICH AUSTRALIA PTY LTD | Australia | Tablet | 19.3K | NOS | $1.75 | $34K | BANGALORE AIR | SYDNEY | AIR |
| 5 | Nov 2025 | MEDREICH AUSTRALIA PTY LTD | Australia | Tablet | 19.4K | NOS | $0.192 | $4K | BANGALORE AIR | SYDNEY | AIR |
| 6 | Dec 2025 | MEDREICH AUSTRALIA PTY LTD | Australia | Tablet | 6.9K | NOS | $1.75 | $12K | BANGALORE ICD | SYDNEY | ICD |
| 7 | Dec 2025 | MEDREICH AUSTRALIA PTY LTD | Australia | Tablet | 6.9K | NOS | $1.75 | $12K | BANGALORE ICD | SYDNEY | ICD |
| SUPPLIER #2 — PROSFORA TECHNOLOGIES PVT LTD · 1 shipments · $5K | |||||||||||
| 8 | Oct 2025 | NEO HEALTH (OTC) PTY LTD | Australia | Tablet | 3.8K | NOS | $1.42 | $5K | NHAVA SHEVA SEA (JNPT) | Sydney | SEA |
| SUPPLIER #3 — HLL LIFECARE LTD · 2 shipments · $65.27 | |||||||||||
| 9 | Dec 2025 | REPUBLIC OF NAURU - DEPARTMENT OF H | Nauru | Suppository | 400 | NOS | $0.020 | $8.16 | DELHI AIR | NAURU ISLAND | AIR |
| 10 | Dec 2025 | REPUBLIC OF NAURU - DEPARTMENT OF H | Nauru | Tablet | 2.8K | NOS | $0.020 | $57.12 | DELHI AIR | NAURU ISLAND | AIR |
| SUPPLIER #4 — WORLDWIDE SKY TRADING (INDIA) · 1 shipments · $14.38 | |||||||||||
| 11 | Nov 2025 | M/S.CHEMCARE GROUP LTD | Papua New Guinea | Tablet | 90 | NOS | $0.160 | $14.38 | MUMBAI AIR (SAHAR) | PORT MORESBY | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 54 Indian bisacodyl exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped bisacodyl in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | DRREDDYS LABORATORIES LTD | Medchel Malkajgiri Dist | 6 | $132K | Tablet | Europe |
| 2 | MEDREICH LTD | BENGALURU | 7 | $99K | Tablet | Oceania |
| 3 | ELYSIUM PHARMACEUTICALS LTD | DIST. VADODARA | 1 | $55K | Tablet | Americas |
| 4 | LUCENT BIOTECH LTD | ROORKEE | 6 | $45K | Tablet | Americas |
| 5 | S KANT HEALTHCARE LTD | VAPI | 1 | $44K | Tablet | Europe |
| 6 | AUROBINDO PHARMA LTD | PARAWADA | 2 | $37K | Tablet | Europe |
| 7 | ZYDUS LIFESCIENCES LTD | AHMEDABAD | 4 | $32K | Suppository | Asia |
| 8 | TRUECARE BIOMEDIX | BALASINOR | 2 | $29K | Tablet | Americas |
| 9 | IND SWIFT LTD | MOHALI | 1 | $20K | Tablet | Europe |
| 10 | EVOLET HEALTHCARE PVT LTD | GURGRAM | 2 | $14K | Tablet, Suppository | Asia |
| 11 | NEM LABORATORIES PVT LTD | MUMBAI | 1 | $13K | Tablet | Africa |
| 12 | ADCOCK INGRAM LTD | BANGALORE | 1 | $12K | Tablet | Africa |
| 13 | CENTURION LABORATORIES PVT LTD | MANJUSAR | 1 | $10K | Tablet | Africa |
| 14 | AGOG PHARMA LTD | VASAI EAST | 2 | $10K | Tablet | Africa |
| 15 | AXELIA | MUMBAI | 5 | $9K | Tablet | Africa |
| 16 | VIDACARE MEDICA PVT LTD | MUMBAI | 4 | $9K | Tablet | Africa |
| 17 | LABORATE PHARMACEUTICALS INDIA LTD | HIMANCHAL PRADESH | 1 | $9K | Tablet | Asia |
| 18 | OCEAN HEALTHCARE PVT LTD | THIRUKALUKUNDRAM | 1 | $9K | Tablet | Americas |
| 19 | INFUGEN PHARMA PVT LTD | N/A | 2 | $8K | Tablet | Africa |
| 20 | JUVENCIA LIFESCIENCES PVT LTD | AHMEDABAD | 3 | $7K | Tablet, Suppository | Americas |
| 21 | RHOMBUS PHARMA PVT LTD | LAKSHMANPURA | 1 | $7K | Tablet | Americas |
| 22 | FREDUN PHARMACEUTICALS LTD | MUMBAI | 2 | $5K | Tablet | Asia |
| 23 | PROSFORA TECHNOLOGIES PVT LTD | KHARGHAR | 1 | $5K | Tablet | Oceania |
| 24 | MARKSANS PHARMA LTD | MUMBAI | 1 | $5K | Suppository | Asia |
| 25 | BDH INDUSTRIES LTD | MUMBAI MAHARASHTRA | 1 | $5K | Tablet | Americas |
| 26 | BIOMATRIX HEALTHCARE PVT LTD | AHMADABAD | 4 | $4K | Tablet | Africa |
| 27 | SAVORITE PHARMACEUTICALS PVT LTD | VADODARA | 2 | $3K | Tablet | Africa |
| 28 | FOURRTS (INDIA) LABORATORIES PVT LTD | CHENNAI | 1 | $3K | Tablet | Africa |
| 29 | BHUMI PHARMACEUTICALS | VADODARA | 1 | $1K | Tablet | Africa |
| 30 | HIRAL LABS LTD | Roorkee | 1 | $1K | Tablet | Asia |
| 31 | PATSONS INTERNATIONAL | ANAND | 1 | $995.63 | Tablet | Africa |
| 32 | KERK | DELHI | 1 | $529.39 | Tablet | Asia |
| 33 | DRIVECURE HEALTHCARE PVT LTD | PUNE | 2 | $352.83 | Tablet | Africa |
| 34 | VEA IMPEX (I) PVT LTD | MUMBAI | 10 | $350.19 | Tablet, Suppository | Africa, Asia |
| 35 | NARAYANA HRUDAYALAYA LTD | BANGALORE | 6 | $325.37 | Tablet, Suppository | Americas |
| 36 | FLAGSHIP BIOTECH INTERNATIONAL PVT LTD | Kalyan | 1 | $316.41 | Tablet | Americas |
| 37 | TRIDENT IMPEX | MUMBAI | 1 | $216.74 | Tablet | Africa |
| 38 | MDS ENTERPRISES | MUMBAI | 5 | $208.51 | Suppository, Tablet | Africa, Asia |
| 39 | SANSKRUTI PHARMA | SURAT | 3 | $173.57 | Tablet | Africa |
| 40 | AASHIRWAD PHARMA INTERNATIONAL PVT LTD | Pune | 1 | $145.47 | Tablet | Americas |
| 41 | AZKA MEDTRADE AND SERVICES | MUMBAI | 1 | $107.60 | Tablet | Africa |
| 42 | HLL LIFECARE LTD | UTTAR PRADESH | 3 | $77.25 | Tablet, Suppository | Africa, Oceania |
| 43 | SANITAS MEDTECH INSTITUTE PVT LTD | Narhen | 1 | $36.59 | Tablet | Asia |
| 44 | SUNNY PHARMA | ADIPUR-KUTCH | 1 | $29.04 | Tablet | Americas |
| 45 | MEDMALL PHARMACY PVT LTD | HYDERABAD | 1 | $28.47 | Tablet | Africa |
| 46 | SHARVIK IMPEX (INDIA) PVT LTD | NAGPUR (M.S.) | 2 | $20.16 | Tablet | Americas |
| 47 | RUCHA ENTERPRISES | MUMBAI | 8 | $14.56 | Tablet | Europe, Americas |
| 48 | WORLDWIDE SKY TRADING (INDIA) | NEW LINK ROAD MALAD WEST | 1 | $14.38 | Tablet | Oceania |
| 49 | PEAK HEALTHCARE | MUMBAI | 3 | $11.38 | Tablet | Americas |
| 50 | RUTVA MEDICARE | SURAT | 1 | $1.63 | Tablet | Africa |
| 51 | MOVID IMPEX | MUMBAI | 1 | $0.693 | Tablet | Asia |
| 52 | NAMAN GLOBAL IMPEX PVT LTD | MUMBAI | 1 | $0.380 | Tablet | Africa |
| 53 | AL-SUPREME EXPORTS | NAGERCOIL | 1 | $0.159 | Suppository | Africa |
| 54 | WHITE LOTUS HEALTHCARE | SURAT | 1 | $0.061 | Suppository | Americas |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 41 global bisacodyl importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian bisacodyl in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | MOVIANTO UK LTD | United Kingdom | 6 | $132K | DRREDDYS LABORATORIE… | Tablet |
| 2 | MEDREICH AUSTRALIA PTY LTD | Australia | 5 | $75K | MEDREICH LTD | Tablet |
| 3 | HHH PHARMACEUTICALS | United States | 2 | $64K | ELYSIUM PHARMACEUTIC… | Tablet |
| 4 | AUROBINDO PHARMA B.V | Netherlands | 1 | $37K | AUROBINDO PHARMA LTD | Tablet |
| 5 | HEMAS PHARMACEUTICALS (PVT) LTD | Sri Lanka | 4 | $32K | ZYDUS LIFESCIENCES LTD | Suppository |
| 6 | STRIVE PHARMACEUTICALS INC | United States | 2 | $29K | TRUECARE BIOMEDIX | Tablet |
| 7 | GENESIS PHARMACEUTICALS LTD | United Kingdom | 1 | $20K | IND SWIFT LTD | Tablet |
| 8 | MADAD PHARM LLC | Tajikistan | 2 | $14K | EVOLET HEALTHCARE PV… | Tablet, Suppository |
| 9 | RENE PHARMACY LTD | Uganda | 1 | $13K | NEM LABORATORIES PVT… | Tablet |
| 10 | ADCOCK INGRAM LTD | South Africa | 1 | $12K | ADCOCK INGRAM LTD | Tablet |
| 11 | VIATRIS NEW ZEALAND | New Zealand | 1 | $12K | MEDREICH LTD | Tablet |
| 12 | BIOGEN PHARMA LTD | Uganda | 1 | $10K | CENTURION LABORATORI… | Tablet |
| 13 | GITTOES PHARMACEUTICALS LTD | Kenya | 2 | $10K | AGOG PHARMA LTD | Tablet |
| 14 | MEDICO PLUS | DR Congo | 4 | $7K | AXELIA | Tablet |
| 15 | LABORATORIO QUIM-FAR, C.A | Venezuela | 1 | $7K | RHOMBUS PHARMA PVT LTD | Tablet |
| 16 | PRINCE FARMA SA | Angola | 2 | $6K | VIDACARE MEDICA PVT … | Tablet |
| 17 | GEORGE STEUART HEALTH PVT LTD | Sri Lanka | 2 | $5K | FREDUN PHARMACEUTICA… | Tablet |
| 18 | NEO HEALTH (OTC) PTY LTD | Australia | 1 | $5K | PROSFORA TECHNOLOGIE… | Tablet |
| 19 | ORGANO COMPANY FOR TRADING PHARMACE | Turkey | 1 | $5K | MARKSANS PHARMA LTD | Suppository |
| 20 | KARIMED PHARMACEUTICALS LTD | Trinidad and Tobago | 1 | $5K | BDH INDUSTRIES LTD | Tablet |
| 21 | ACE HEALTH CARE LDA | Mozambique | 1 | $4K | BIOMATRIX HEALTHCARE… | Tablet |
| 22 | STE PRINCE PHARMA SARL | DR Congo | 2 | $3K | VIDACARE MEDICA PVT … | Tablet |
| 23 | T.CHOITHRAM & SONS (LIB) INC | Liberia | 1 | $3K | FOURRTS (INDIA) LABO… | Tablet |
| 24 | SBR GROUP OF COMPANIES | Liberia | 1 | $1K | BHUMI PHARMACEUTICALS | Tablet |
| 25 | UBSA PHARMA INDUSTRIES S.A | Lebanon | 1 | $1K | HIRAL LABS LTD | Tablet |
| 26 | LUSAKA PHARMACEUTICALS LTD | Zambia | 1 | $995.63 | PATSONS INTERNATIONAL | Tablet |
| 27 | MUBARAK HASHIMI LTD | Afghanistan | 1 | $529.39 | KERK | Tablet |
| 28 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | 6 | $325.37 | NARAYANA HRUDAYALAYA… | Tablet, Suppository |
| 29 | ALLIANCE PHARMA SARL | Guinea-Bissau | 1 | $216.74 | TRIDENT IMPEX | Tablet |
| 30 | HEALTH PLUS PHARMACY | Saint Kitts and Nevis | 1 | $145.47 | AASHIRWAD PHARMA INT… | Tablet |
| 31 | REPUBLIC OF NAURU - DEPARTMENT OF H | Nauru | 2 | $65.27 | HLL LIFECARE LTD | Suppository, Tablet |
| 32 | SUCCESS INTER LINK PTE LTD | Singapore | 1 | $36.59 | SANITAS MEDTECH INST… | Tablet |
| 33 | CENTRAL MEDICAL STORES, MINISTRY OF | Montserrat | 1 | $29.04 | SUNNY PHARMA | Tablet |
| 34 | PRISM INTERNATIONAL LLC | Seychelles | 1 | $28.47 | MEDMALL PHARMACY PVT… | Tablet |
| 35 | JOAN DAVIS | Jamaica | 2 | $20.16 | SHARVIK IMPEX (INDIA… | Tablet |
| 36 | M/S.CHEMCARE GROUP LTD | Papua New Guinea | 1 | $14.38 | WORLDWIDE SKY TRADIN… | Tablet |
| 37 | MINISTRY OF HEALTH | Seychelles | 1 | $11.98 | HLL LIFECARE LTD | Tablet |
| 38 | APL SWIFT SERVICES (MALTA) LTD | Malta | 1 | $11.95 | AUROBINDO PHARMA LTD | Tablet |
| 39 | TO THE INVOICE RAISED TO MANGER OF | Seychelles | 1 | $9.95 | DRIVECURE HEALTHCARE… | Tablet |
| 40 | EMIRATES POST GROUP | United Arab Emirates | 1 | $0.693 | MOVID IMPEX | Tablet |
| 41 | GOOD HEALTH (PTY) LTD | Seychelles | 1 | $0.159 | AL-SUPREME EXPORTS | Suppository |
This report covers 125 2025-Q4 Bisacodyl shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/bisacodyl
Talk to our trade analyst
Need a custom bisacodyl report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/bisacodyl
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Bisacodyl product page
Live data, supplier directory, price trends, and trade route analysis